CN100467680C - Antibacterial silk composite nanofiber material and preparation method thereof - Google Patents
Antibacterial silk composite nanofiber material and preparation method thereof Download PDFInfo
- Publication number
- CN100467680C CN100467680C CNB2006100410162A CN200610041016A CN100467680C CN 100467680 C CN100467680 C CN 100467680C CN B2006100410162 A CNB2006100410162 A CN B2006100410162A CN 200610041016 A CN200610041016 A CN 200610041016A CN 100467680 C CN100467680 C CN 100467680C
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- solution
- silk
- spinning
- silk composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 44
- 239000000463 material Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000002121 nanofiber Substances 0.000 title claims description 38
- 239000002131 composite material Substances 0.000 title claims description 22
- 238000009987 spinning Methods 0.000 claims abstract description 39
- 239000000835 fiber Substances 0.000 claims abstract description 15
- 229920002101 Chitin Polymers 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 8
- 239000002798 polar solvent Substances 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 4
- 108010022355 Fibroins Proteins 0.000 claims description 34
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 10
- 229960000583 acetic acid Drugs 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 7
- 239000006258 conductive agent Substances 0.000 claims description 7
- 235000019253 formic acid Nutrition 0.000 claims description 7
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 5
- -1 biguanides acetate Chemical class 0.000 claims description 5
- 229940123208 Biguanide Drugs 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 230000005251 gamma ray Effects 0.000 claims description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 3
- 239000001263 FEMA 3042 Substances 0.000 claims description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004327 boric acid Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 3
- 229920002258 tannic acid Polymers 0.000 claims description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 3
- 229940033123 tannic acid Drugs 0.000 claims description 3
- 235000015523 tannic acid Nutrition 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 238000010041 electrostatic spinning Methods 0.000 claims 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- 239000012456 homogeneous solution Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 abstract description 19
- 239000012528 membrane Substances 0.000 abstract description 16
- 229920001661 Chitosan Polymers 0.000 abstract description 12
- 230000035699 permeability Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 9
- 108010013296 Sericins Proteins 0.000 abstract description 6
- 239000012567 medical material Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 3
- 230000003068 static effect Effects 0.000 abstract description 3
- 239000004753 textile Substances 0.000 abstract 3
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005611 electricity Effects 0.000 abstract 1
- 239000002657 fibrous material Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 238000005325 percolation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 238000001523 electrospinning Methods 0.000 description 8
- 238000000520 microinjection Methods 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000001110 calcium chloride Substances 0.000 description 6
- 229910001628 calcium chloride Inorganic materials 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000007602 hot air drying Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OSNIIMCBVLBNGS-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one Chemical compound CN(C)C(C)C(=O)C1=CC=C2OCOC2=C1 OSNIIMCBVLBNGS-UHFFFAOYSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- VGBWDOLBWVJTRZ-UHFFFAOYSA-K cerium(3+);triacetate Chemical compound [Ce+3].CC([O-])=O.CC([O-])=O.CC([O-])=O VGBWDOLBWVJTRZ-UHFFFAOYSA-K 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000001937 non-anti-biotic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 231100000202 sensitizing Toxicity 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Nonwoven Fabrics (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种医用生物材料及其制备方法,特别涉及一种丝素蛋白与抗菌剂等复合而成的纳米纤维抗菌材料及其制备方法,属于高分子材料技术领域。The invention relates to a medical biological material and a preparation method thereof, in particular to a nanofiber antibacterial material composed of silk fibroin and an antibacterial agent and a preparation method thereof, belonging to the technical field of polymer materials.
背景技术 Background technique
本发明作出之前,在利用天然或合成高聚物为主要原料,经静电纺丝制成纳米纤维无纺膜方面已有报道,例如:原料为聚丙烯腈、聚酰胺、聚乙烯醇、纤维素及其衍生物等,但上述材料有的与人体相容性差,有的纺成的纤维较粗,平均直径达几百至几千纳米,不适合作为医用材料。Before the present invention was made, there were reports on the use of natural or synthetic high polymers as main raw materials to make nanofiber non-woven membranes through electrospinning, such as: raw materials are polyacrylonitrile, polyamide, polyvinyl alcohol, cellulose And its derivatives, etc., but some of the above materials have poor compatibility with the human body, and some spun fibers are relatively thick, with an average diameter of several hundred to several thousand nanometers, which are not suitable for medical materials.
蚕丝蛋白是一种相当纯的天然蛋白,由十八种氨基酸组成,与人体的胶原蛋白有较大的相似性,它无毒、无刺激、具有良好的生物相容性,因此蚕丝蛋白是制备医用生物材料理想的基础原料。也有利用蚕丝蛋白经静电纺丝制成纳米纤维无纺膜,但其无抗菌性能,使用范围受到了一定的限制。Silk protein is a fairly pure natural protein, which is composed of 18 kinds of amino acids. It has a great similarity with human collagen. It is non-toxic, non-irritating, and has good biocompatibility. Therefore, silk protein is the preparation Ideal basic raw material for medical biomaterials. There is also a nanofiber non-woven film made of silk protein by electrospinning, but it has no antibacterial properties, and its application range is limited to a certain extent.
公开号为CN1348820A的中国发明专利“一种抗菌丝素创面保护膜及其制备方法”,公开了以蚕丝为主要成膜原料,加入抗菌剂和添加剂,采用流涎法经分层涂布热风干燥加工制得的抗菌丝素创面保护膜,这是通过热风干燥而成的致密膜,虽具有良好的抗菌作用,但因热风干燥会影响丝素创面保护膜的柔韧性;又因膜致密、无贯通孔隙而影响其透水透气性,不利于创面的愈合,效果受到了一定的影响。The Chinese invention patent with the publication number CN1348820A "An Antibacterial Silk Fibroin Wound Protective Film and Its Preparation Method" discloses that silk is used as the main film-forming raw material, antibacterial agents and additives are added, and the salivation method is applied through layered coating and hot air drying. The prepared antibacterial silk fibroin wound protective film is a dense film formed by hot air drying. Although it has a good antibacterial effect, the flexibility of the silk fibroin wound protective film will be affected by hot air drying; Pores affect its water permeability and air permeability, which is not conducive to wound healing, and the effect is affected to a certain extent.
发明内容 Contents of the invention
本发明的目的克服现有技术存在的不足,提供一种既与人体相容性好,又具有优异抗菌性、透水透气性的医用抗菌创面覆盖材料及其制备方法。The purpose of the present invention is to overcome the deficiencies of the prior art, and to provide a medical antibacterial wound covering material with good compatibility with the human body, excellent antibacterial properties, water permeability and air permeability, and a preparation method thereof.
本发明所述的一种抗菌蚕丝复合纳米纤维材料,其特征在于:它为纳米纤维无纺膜结构,平均孔径为0.5~5.0μm,孔隙率为60~90%,纤维的平均直径为40~100nm;它的组分及各组分以重量计的比例为:丝素蛋白58~90%,壳聚糖或甲壳素0~40%,抗菌剂0~5%,导电剂1~4%,交联剂1~4%;所述的抗菌剂为季铵盐、胍类、聚胍类以及含Ag+、Zn2+金属离子的盐类中的一种或几种;所述的导电剂为硼酸盐、醋酸盐、硅酸盐中的一种或几种;所述的交联剂为鞣酸、柠檬酸、季戊四醇、硼酸中的一种或几种。An antibacterial silk composite nanofiber material according to the present invention is characterized in that it is a nanofiber non-woven membrane structure with an average pore diameter of 0.5-5.0 μm, a porosity of 60-90%, and an average fiber diameter of 40-5.0 μm. 100nm; its components and the proportions by weight of each component are: silk fibroin 58-90%, chitosan or chitin 0-40%, antibacterial agent 0-5%, conductive agent 1-4%, 1-4% crosslinking agent; the antibacterial agent is one or more of quaternary ammonium salts, guanidines, polyguanidines, and salts containing Ag + , Zn 2+ metal ions; the conductive agent It is one or more of borates, acetates and silicates; the crosslinking agent is one or more of tannic acid, citric acid, pentaerythritol and boric acid.
制备抗菌蚕丝复合纳米纤维材料的方法,先将蚕丝经脱胶、溶解、透析、纯化、干燥,得到纯的丝素蛋白,其特征在于再进行如下步骤的加工:The method for preparing antibacterial silk composite nanofiber material, first degumming, dissolving, dialysis, purifying and drying the silk to obtain pure silk fibroin, which is characterized in that the processing is carried out in the following steps:
a、将纯的丝素蛋白、壳聚糖或甲壳素或抗菌剂分别溶解于极性溶剂中,再将它们充分混合后制成均匀溶液,所述的极性溶剂为冰醋酸、二甲基甲酰胺、无水甲酸、三氟乙醇中的一种或几种;a. Dissolve pure silk fibroin, chitosan or chitin or antibacterial agents in polar solvents respectively, and then fully mix them to make a uniform solution. The polar solvents are glacial acetic acid, dimethyl One or more of formamide, anhydrous formic acid, and trifluoroethanol;
b、在上述溶液中加入导电剂、交联剂,制备质量分数为8~20%的纺丝原液,溶质中的组分及各组分以重量计的比例为:丝素蛋白58~90%,壳聚糖或甲壳素0~40%,抗菌剂0~5%,导电剂1~4%,交联剂1~4%;b. Add a conductive agent and a cross-linking agent to the above solution to prepare a spinning stock solution with a mass fraction of 8-20%. The components in the solute and the proportions by weight of each component are: silk fibroin 58-90% , chitosan or chitin 0-40%, antibacterial agent 0-5%, conductive agent 1-4%, cross-linking agent 1-4%;
c、将上述纺丝原液采用静电纺丝工艺,在接收板上得到平均孔径为0.5~5.0μm,孔隙率为60~90%,纤维平均直径为40~100nm的抗菌蚕丝复合纳米纤维无纺膜。c. Using the electrospinning process for the above spinning stock solution, an antibacterial silk composite nanofiber nonwoven membrane with an average pore size of 0.5-5.0 μm, a porosity of 60-90%, and an average fiber diameter of 40-100 nm is obtained on the receiving plate .
上述静电纺丝的工艺条件为:电压15~35KV,纺丝距离7~20cm,纺丝液喂入量0.1~3.0ml/h。The technological conditions of the above electrospinning are: voltage 15-35KV, spinning distance 7-20cm, feeding amount of spinning solution 0.1-3.0ml/h.
将上述制得的抗菌蚕丝复合纳米纤维无纺膜再经γ射线辐照。The antibacterial silk composite nanofiber nonwoven membrane prepared above is irradiated with gamma rays.
与现有技术相比,本发明提供的抗菌蚕丝复合纳米纤维材料的优点是:Compared with the prior art, the advantages of the antibacterial silk composite nanofiber material provided by the present invention are:
1、它以蚕丝为主要原料,而蚕丝是一种相当纯的天然蛋白,与人体有很好的组织相容性,无毒、无刺激和致敏性,因此,制成的创面医用材料与创面具有良好的粘合力。1. It uses silk as the main raw material, and silk is a relatively pure natural protein, which has good tissue compatibility with the human body, is non-toxic, non-irritating and sensitizing. Therefore, the wound medical material made is compatible with The wound surface has good adhesion.
2、在蚕丝蛋白中复合了壳聚糖或甲壳素以及抗菌剂,而壳聚糖或甲壳素是一种具有抗菌性的天然高聚物;所用的抗菌剂为非抗生素类,其抗菌谱广,对金黄色葡萄球菌、大肠杆菌和绿脓杆菌有优异的杀灭作用,对人体副作用小,毒性低,对皮肤无刺激作用,光、热稳定性好,它们与丝素可溶于同种溶剂中,形成均匀的纺丝液,经静电纺丝形成的复合纳米纤维无纺膜中,壳聚糖、抗菌剂等能与丝素蛋白均匀复合共混于纳米纤维无纺膜内,由于纳米纤维比表面积大,壳聚糖类按接触障碍杀菌机理作用,显示优异的杀菌性;由于抗菌剂均匀分布于纳米纤维内,纤维细,比表面积大,因此,其初始释放浓度大,使释药浓度超过药物最低杀菌浓度而具有优异的杀菌作用,又因该无纺膜是由许多纳米纤维纵横交叉层迭而成,药物需从纤维内部逐渐向外释放,因此,膜中抗菌剂可持续释放,而保持药效的持久性。2. Chitosan or chitin and antibacterial agents are compounded in silk protein, and chitosan or chitin is a natural high polymer with antibacterial properties; the antibacterial agents used are non-antibiotics and have a wide antibacterial spectrum , has excellent killing effect on Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, has little side effects on the human body, low toxicity, no irritation to the skin, good light and heat stability, and they are soluble in the same species as silk fibroin In the solvent, a uniform spinning solution is formed, and in the composite nanofiber nonwoven membrane formed by electrospinning, chitosan, antibacterial agent, etc. can be evenly compounded and blended with silk fibroin in the nanofiber nonwoven membrane. The specific surface area of the fiber is large, and chitosan acts according to the bactericidal mechanism of contact barriers, showing excellent bactericidal properties; because the antibacterial agent is evenly distributed in the nanofibers, the fibers are thin and the specific surface area is large, so the initial release concentration is large, making the drug release The concentration exceeds the minimum bactericidal concentration of the drug, so it has excellent bactericidal effect, and because the non-woven film is composed of many nanofibers, the drug needs to be released gradually from the inside of the fiber, so the antibacterial agent in the film can be released continuously , while maintaining the persistence of the drug effect.
3、由于静电纺丝形成的纳米纤维无纺膜间有大量上下贯通的孔隙,因此,具有优异的透水透气性,有利于创面治疗。还由于静电纺丝在室温下进行,因此,抗菌剂不会受到温度的影响而引起药物的成分变化,保证良好的使用效果。3. Since the nanofiber non-woven membrane formed by electrospinning has a large number of pores that penetrate up and down, it has excellent water permeability and air permeability, which is beneficial to wound treatment. Also, because the electrospinning is carried out at room temperature, the antibacterial agent will not be affected by the temperature and cause changes in the composition of the drug, ensuring a good use effect.
4、该抗菌蚕丝复合纳米纤维材料经辐照消毒后作为创面医用材料,其外观白色、厚度均匀、光滑、平整、柔软、不易破损、使用十分方便。4. The antibacterial silk composite nanofiber material is used as a wound medical material after being irradiated and sterilized. Its appearance is white, uniform in thickness, smooth, flat, soft, not easy to break, and very convenient to use.
附图说明 Description of drawings
图1是按本发明实施例1所提供的技术方案制得的抗菌蚕丝复合纳米纤维材料的扫描电镜(SEM)图;Fig. 1 is the scanning electron microscope (SEM) figure of the antibacterial silk composite nanofiber material that the technical scheme that provides by the embodiment of the present invention 1 makes;
图2是按本发明实施例3所提供的技术方案制备得到的抗菌蚕丝复合纳米纤维材料的SEM图。Fig. 2 is a SEM image of the antibacterial silk composite nanofiber material prepared according to the technical solution provided in Example 3 of the present invention.
具体实施方式 Detailed ways
下面结合实施例对本发明作进一步的阐述。The present invention will be further elaborated below in conjunction with embodiment.
实施例一:Embodiment one:
1.将0.1公斤下脚蚕丝放入3升质量分数为0.05%的碳酸钠水溶液中,煮沸0.5小时,重复处理三次,脱尽蚕丝外围的丝胶,得到丝素;1. Put 0.1 kg of leftover silk into 3 liters of 0.05% sodium carbonate aqueous solution by mass fraction, boil for 0.5 hour, repeat the treatment three times, remove all the sericin around the silk, and obtain silk fibroin;
2.将所得丝素干燥后,用0.6升摩尔比为1:8:2的氯化钙、水、乙醇溶液,在78±2℃下加热溶解成蚕丝蛋白溶液;2. After drying the obtained silk fibroin, use 0.6 liter of calcium chloride, water and ethanol solution with a molar ratio of 1:8:2 to heat and dissolve at 78±2°C to form a silk protein solution;
3.将上述蚕丝蛋白溶液倒入纤维素半透膜中,先用自来水透析,再用去离子水透析,以除去溶液中的乙醇和氯化钙小分子,再用多层脱脂纱布过滤,制得纯丝素蛋白溶液;3. Pour the above-mentioned silk protein solution into the cellulose semi-permeable membrane, dialyze with tap water first, and then dialyze with deionized water to remove ethanol and calcium chloride small molecules in the solution, and then filter with multi-layer degreasing gauze to prepare Obtain pure silk fibroin solution;
4.分别取100ml纯丝素蛋白溶液倒入面积为20×20cm2的聚苯乙烯(ABS)盘中,在25℃、RH 65%的恒温恒湿条件下干燥成膜,取下再生丝素膜装袋待用;4. Take 100ml of pure silk fibroin solution and pour it into a polystyrene (ABS) dish with an area of 20× 20cm2 , dry it to form a film at 25°C and constant temperature and humidity of RH 65%, and remove the regenerated silk fibroin Film bagged for use;
5.将3.6克壳聚糖加入16克冰醋酸中,搅拌30分钟制得壳聚糖醋酸溶液;5. 3.6 gram chitosan was added in 16 gram glacial acetic acid, stirred 30 minutes and made chitosan acetic acid solution;
6.用上述再生丝素膜8.04克加入到72克无水甲酸中,搅拌45分钟;6. Add 8.04 grams of the above-mentioned regenerated silk fibroin film to 72 grams of anhydrous formic acid, and stir for 45 minutes;
7.将步骤5所得的壳聚糖醋酸溶液加入步骤6所得的再生丝素甲酸溶液中,充分搅拌后,再加入硼酸钠和鞣酸各0.18克,继续搅拌溶解至形成均匀的纺丝原液100克,其纺丝液质量分数为12%;7. Add the chitosan acetic acid solution obtained in step 5 into the regenerated silk fibroin formic acid solution obtained in step 6, after fully stirring, add 0.18 grams each of sodium borate and tannic acid, continue stirring and dissolving to form a uniform spinning stock solution 100 Gram, its spinning solution mass fraction is 12%;
8.将所制得的100克纺丝原液通过微量注射泵注入到纺丝管中;8. Inject 100 grams of the prepared spinning stock solution into the spinning tube through a micro-injection pump;
9.调节静电发生器的静电压为30kV、纺丝距离为12cm,微量注射泵纺丝液的喂入量为0.5ml/h,纺丝液通过纺丝管前的金属针头连续喷出,极性溶剂冰醋酸和无水甲酸在空气中挥发,在接收板上可收集到12克蚕丝/壳聚糖复合纳米纤维无纺膜,可制得面积为15×15cm2、厚度约为0.015mm的医用抗菌创面膜25张左右。根据静电纺丝的原理,可通过调节纺丝液的质量分数、静电压、纺丝距离、纺丝液的喂入量和纺丝时间等,以满足所需要的纳米纤维的直径、孔径、孔隙率及其无纺膜的厚度等参数要求。9. Adjust the electrostatic voltage of the electrostatic generator to 30kV, the spinning distance to 12cm, and the feeding volume of the spinning solution of the micro-injection pump to 0.5ml/h. The spinning solution is continuously sprayed out through the metal needle in front of the spinning tube, which is extremely The solvent glacial acetic acid and anhydrous formic acid are volatilized in the air, and 12 grams of silk/chitosan composite nanofiber non-woven film can be collected on the receiving plate, and a non-woven film with an area of 15×15 cm 2 and a thickness of about 0.015 mm can be obtained. About 25 pieces of medical antibacterial wound mask. According to the principle of electrospinning, the diameter, pore size and pore size of nanofibers can be met by adjusting the mass fraction of spinning solution, static voltage, spinning distance, feeding amount of spinning solution and spinning time, etc. Ratio and the thickness of the non-woven film and other parameters.
10.将所制得的无纺膜经真空干燥箱平衡12h后,用双层塑料袋包装并在高频封口机上封口,然后用γ射线辐照消毒备用。10. After the prepared non-woven film was equilibrated in a vacuum drying oven for 12 hours, it was packed in a double-layer plastic bag and sealed on a high-frequency sealing machine, and then sterilized by γ-ray irradiation for use.
参见附图1,按本实施例所提供的技术方案制得的抗菌蚕丝复合纳米纤维材料,其纤维的平均直径约为82nm,由图1可见,纳米纤维无纺膜间具有上下贯通的孔隙,平均孔径约为0.6μm、孔隙率约为75%。Referring to accompanying drawing 1, the antibacterial silk composite nanofiber material that the technical scheme provided by the present embodiment makes, the average diameter of its fiber is about 82nm, as seen from Fig. 1, there is the hole through up and down between the nanofiber nonwoven film, The average pore diameter is about 0.6 μm, and the porosity is about 75%.
实施例二:Embodiment two:
1.将0.2公斤废桑蚕丝放入6升质量分数为0.05%的碳酸钠水溶液中,煮沸0.5小时,重复处理三次,脱尽蚕丝外围的丝胶,得到丝素,室温下晾干;1. Put 0.2 kg of waste mulberry silk into 6 liters of aqueous sodium carbonate solution with a mass fraction of 0.05%, boil for 0.5 hour, repeat the treatment three times, remove all the sericin around the silk to obtain silk fibroin, and dry at room temperature;
2.将干燥丝素用1.2升摩尔比为1:8:2的氯化钙、水、乙醇溶液,在78±2℃下加热溶解成蚕丝蛋白溶液;2. Dissolve the dried silk fibroin with 1.2 liters of calcium chloride, water and ethanol solution with a molar ratio of 1:8:2 at 78±2°C to form a silk protein solution;
3.将步骤2制得的蚕丝蛋白溶液倒入纤维素透析袋中,先用自来水透析,再用去离子水透析,以除去溶液中的乙醇和氯化钙,再用脱脂纱布过滤,制得纯丝素蛋白溶液;3. Pour the fibroin solution prepared in step 2 into a cellulose dialysis bag, first dialyze with tap water, then dialyze with deionized water to remove ethanol and calcium chloride in the solution, and then filter with degreasing gauze to obtain Pure silk fibroin solution;
4.取100ml纯丝素蛋白溶液倒入不锈钢盘中,在-25℃下冷冻12h,再置于冷冻干燥机内真空干燥24h,制得海绵状丝素膜,装袋待用;4. Pour 100ml of pure silk fibroin protein solution into a stainless steel plate, freeze at -25°C for 12 hours, and then vacuum-dry it in a freeze dryer for 24 hours to obtain a spongy silk fibroin film, which is bagged for use;
5.将由步骤4所得的海绵状丝素膜6.7克加入到73克的三氟乙醇中,搅拌45分钟;5. 6.7 grams of the spongy silk film obtained in step 4 were added to 73 grams of trifluoroethanol, and stirred for 45 minutes;
6.称取3.0克甲壳素加入到17克三氟乙醇中,搅拌30分钟;6. Weigh 3.0 grams of chitin and add it to 17 grams of trifluoroethanol, and stir for 30 minutes;
7.将步骤6中所得的甲壳素溶液加入步骤5所得的丝素溶液中,充分搅拌后,再加入醋酸铈和季戊四醇各0.15克,继续搅拌至形成均匀的纺丝液100克,纺丝液质量分数为10%;7. Add the chitin solution obtained in step 6 into the silk fibroin solution obtained in step 5. After fully stirring, add 0.15 grams each of cerium acetate and pentaerythritol, and continue stirring until 100 grams of uniform spinning solution is formed. The quality score is 10%;
8.将步骤7所制得的100克纺丝液加入微量注射泵,由泵将纺丝液注入纺丝管中;8. Add 100 grams of spinning solution prepared in step 7 to a micro-injection pump, and inject the spinning solution into the spinning tube by the pump;
9.将静电发生器的阳极固定在纺丝管前的金属针头上,阴极接在金属接收板上,调节静电发生器的静电压为32kV、纺丝距离为15cm,开启静电发生器和微量注射泵,调节微量注射泵使纺丝液的喂入量为1.0ml/h,纺丝液通过纺丝管前的金属针头连续喷出,极性溶剂三氟乙醇在空气中挥发,在接收板上可收集到10克蚕丝/甲壳素复合纳米纤维无纺膜,其纤维的平均直径为98nm、纤维间具有上下贯通的孔隙,平均孔径为1.0μm、孔隙率为78%,可制得面积约为15×15cm2、厚度为0.015mm的无纺膜20张左右;9. Fix the anode of the electrostatic generator on the metal needle in front of the spinning tube, connect the cathode to the metal receiving plate, adjust the static voltage of the electrostatic generator to 32kV, and the spinning distance to 15cm, turn on the electrostatic generator and micro-injection Pump, adjust the micro-injection pump so that the feeding amount of the spinning solution is 1.0ml/h, the spinning solution is continuously sprayed out through the metal needle in front of the spinning tube, and the polar solvent trifluoroethanol is volatilized in the air, and on the receiving plate 10 grams of silk/chitin composite nanofiber non-woven membrane can be collected, the average diameter of the fibers is 98nm, there are pores through the fibers, the average pore diameter is 1.0μm, and the porosity is 78%. The area that can be obtained is about About 20 pieces of non-woven film with a size of 15×15cm 2 and a thickness of 0.015mm;
10.将步骤9所制得的无纺膜经真空干燥箱平衡24h后,用双层塑料袋包装并在高频封口机上封口,然后用γ射线辐照消毒备用。10. After the non-woven film prepared in step 9 is balanced in a vacuum drying oven for 24 hours, it is packed in a double-layer plastic bag and sealed on a high-frequency sealing machine, and then sterilized by γ-ray irradiation for use.
上述两个实施例所获得的抗菌蚕丝复合纳米纤维材料,经测试,它们对金黄色葡萄球菌的抑菌率分别为97.8%(6h)、96.2%(6h)和100%(24h);对大肠杆菌的抑菌率分别为99.1%(6h)、97.6%(6h)和100%(24h),具有优异的抗菌性。由于该膜具有大量上下贯通的微孔而具有优异的透水透气性,因此,可用作抗菌创面医用敷料和抗菌口罩等医用材料。The antibacterial silk composite nanofiber materials obtained in the above two examples, after testing, their antibacterial rates to Staphylococcus aureus are respectively 97.8% (6h), 96.2% (6h) and 100% (24h); The antibacterial rates of bacilli were 99.1% (6h), 97.6% (6h) and 100% (24h), respectively, showing excellent antibacterial properties. Because the film has a large number of micropores penetrating up and down and has excellent water permeability and air permeability, it can be used as medical materials such as antibacterial wound medical dressings and antibacterial masks.
实施例三:Embodiment three:
1.将0.2公斤废桑蚕丝放入6升质量分数为0.05%的碳酸钠水溶液中,煮沸0.5小时,重复处理三次,脱尽蚕丝外围的丝胶,得到丝素,室温下晾干;1. Put 0.2 kg of waste mulberry silk into 6 liters of aqueous sodium carbonate solution with a mass fraction of 0.05%, boil for 0.5 hour, repeat the treatment three times, remove all the sericin around the silk, obtain silk fibroin, and dry at room temperature;
2.将干燥丝素用1.2升摩尔比为1:8:2的氯化钙、水、乙醇溶液,在78±2℃下加热溶解成蚕丝蛋白溶液;2. Dissolve the dried silk fibroin with 1.2 liters of calcium chloride, water and ethanol solution with a molar ratio of 1:8:2 at 78±2°C to form a silk protein solution;
3.将步骤2制得的蚕丝蛋白溶液倒入纤维素透析袋中,先用自来水透析,再用去离子水透析,以除去溶液中的乙醇和氯化钙,再用脱脂纱布过滤,制得纯丝素蛋白溶液;3. Pour the fibroin solution prepared in step 2 into a cellulose dialysis bag, first dialyze with tap water, then dialyze with deionized water to remove ethanol and calcium chloride in the solution, and then filter with degreasing gauze to obtain Pure silk fibroin solution;
4.取100ml纯丝素蛋白溶液倒入不锈钢盘中,在-18℃下冷冻8h,再置于冷冻干燥机内真空干燥18h,制得丝素蛋白粉末,装袋待用;4. Pour 100ml of pure silk fibroin solution into a stainless steel plate, freeze at -18°C for 8 hours, and then vacuum-dry it in a freeze dryer for 18 hours to obtain silk fibroin powder, which is bagged for use;
5.将由步骤4所得的丝素粉16.2克加入到73.8克的无水甲酸中,搅拌45分钟;5. Join 16.2 grams of silk fibroin powder gained in step 4 in the anhydrous formic acid of 73.8 grams, stir for 45 minutes;
6.选用抗菌剂双胍醋酸盐0.54克加入到8.2克冰醋酸中,搅拌溶解制得抗菌剂溶液;6. Select 0.54 grams of antibacterial agent biguanide acetate to join in 8.2 grams of glacial acetic acid, stir and dissolve to obtain antibacterial agent solution;
7.将上述抗菌剂溶液加入到步骤5制得的溶液中,充分搅拌后,再分别加入硼酸钠和硼酸各0.63克,继续搅拌溶解至形成均匀的纺丝原液100克;纺丝原液质量分数为18%;7. Add the above-mentioned antibacterial agent solution to the solution prepared in step 5. After fully stirring, add 0.63 grams of sodium borate and boric acid respectively, and continue to stir and dissolve until 100 grams of uniform spinning stock solution is formed; the mass fraction of spinning stock solution is 18%;
8.将步骤6所制得的100克纺丝液通过微量注射泵注入到纺丝管中;8. Inject 100 grams of spinning solution prepared in step 6 into the spinning tube through a micro-injection pump;
9.调节静电发生器的静电压为32kV、纺丝距离为15cm,开启静电发生器和微量注射泵,调节微量注射泵使纺丝液的喂入量为0.8ml/h,纺丝液通过纺丝管前的金属针头连续喷出,极性溶剂冰醋酸和无水甲酸在空气中挥发,在接收板上可收集到18克蚕丝/抗菌药复合纳米纤维无纺膜,可制得15×15cm2、厚度为0.02mm的无纺膜30张左右。每平方厘米纳米纤维无纺膜上含抗菌药0.1~1.5毫克;9. Adjust the electrostatic voltage of the electrostatic generator to 32kV and the spinning distance to 15cm, turn on the electrostatic generator and the micro-injection pump, adjust the micro-injection pump so that the feeding amount of the spinning solution is 0.8ml/h, and the spinning solution passes through the spinning The metal needle in front of the silk tube sprays out continuously, the polar solvents glacial acetic acid and anhydrous formic acid volatilize in the air, and 18 grams of silk/antibacterial drug composite nanofiber non-woven film can be collected on the receiving plate, which can be made into a 15×15cm 2. About 30 sheets of non-woven film with a thickness of 0.02mm. The nanofiber non-woven film contains 0.1-1.5 mg of antibacterial drugs per square centimeter;
10.将步骤9所制得的纤维无纺膜置于真空干燥器抽真空8h后,用双层塑料袋包装并在高频封口机上封口,然后用γ射线辐照消毒备用。10. Put the fiber non-woven membrane prepared in step 9 into a vacuum desiccator for 8 hours, pack it in a double-layer plastic bag and seal it on a high-frequency sealing machine, and then sterilize it with γ-ray irradiation for use.
参见附图2,按本实施例所提供的技术方案制得的抗菌蚕丝复合纳米纤维材料,其纤维直径约为96nm、纳米纤维无纺膜间具有上下贯通的孔隙,平均孔径约为1.2μm、孔隙率约为80%。Referring to accompanying drawing 2, according to the antibacterial silk composite nanofiber material that the technical scheme provided in this embodiment makes, its fiber diameter is about 96nm, has the hole that runs through up and down between the nanofiber non-woven membrane, and average aperture is about 1.2 μ m, The porosity is about 80%.
经测试,该纳米纤维膜对金黄色葡萄球菌和大肠杆菌的抑菌圈分别为16mm和13mm(按测试标准,抑菌圈大于7mm为具有抗菌性),而纯蚕丝纳米纤维无纺膜的抑菌圈为0,由此可见,按本实施例技术方案制备的纳米纤维材料具有优异的抗菌性。经释药性能的测试表明,该抗菌蚕丝复合纳米纤维材料1小时内释药浓度已达到药物的最低杀菌浓度,48h药物仍在持续释放,保持持久的药效。释放速率可通过调节纳米纤维的直径来控制,直径小则因比表面积大而加快释放,从而达到控制释药的效果。又由于该无纺膜具有大量上下贯通的微孔而具有优异的透水透气性,因此可用作抗菌创面医用敷料和口腔溃疡贴膜等医用材料。After testing, the antibacterial zones of the nanofiber membrane to Staphylococcus aureus and Escherichia coli were 16mm and 13mm respectively (according to the test standard, the antibacterial zone is greater than 7mm to have antibacterial properties), while the inhibition zone of the pure silk nanofiber nonwoven membrane The bacterial circle is 0, which shows that the nanofiber material prepared according to the technical solution of this embodiment has excellent antibacterial properties. The test of drug release performance shows that the drug release concentration of the antibacterial silk composite nanofiber material has reached the minimum bactericidal concentration of the drug within 1 hour, and the drug is still released continuously after 48 hours, maintaining a long-lasting drug effect. The release rate can be controlled by adjusting the diameter of nanofibers, and the smaller the diameter, the faster the release due to the larger specific surface area, thereby achieving the effect of controlled drug release. And because the non-woven membrane has a large number of micropores penetrating up and down and has excellent water permeability and air permeability, it can be used as medical materials such as antibacterial wound medical dressings and oral ulcer patches.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100410162A CN100467680C (en) | 2006-07-13 | 2006-07-13 | Antibacterial silk composite nanofiber material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100410162A CN100467680C (en) | 2006-07-13 | 2006-07-13 | Antibacterial silk composite nanofiber material and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1904159A CN1904159A (en) | 2007-01-31 |
CN100467680C true CN100467680C (en) | 2009-03-11 |
Family
ID=37673517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100410162A Expired - Fee Related CN100467680C (en) | 2006-07-13 | 2006-07-13 | Antibacterial silk composite nanofiber material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100467680C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109468705A (en) * | 2016-12-06 | 2019-03-15 | 宁波芸生纺织品科技有限公司 | A kind of biological fibrous material |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766188B (en) * | 2008-12-29 | 2012-03-21 | 张子剑 | Chitosan antimicrobial agent |
KR101060910B1 (en) * | 2009-05-08 | 2011-08-30 | 대한민국(관리부서:농촌진흥청장) | Artificial tympanum using silk protein and its manufacturing method |
CN102040771B (en) * | 2009-10-16 | 2013-02-27 | 中国石油化工股份有限公司 | Antibacterial thermoplastic plastic composition and preparation method thereof |
CN102037988B (en) * | 2009-10-16 | 2013-02-27 | 中国石油化工股份有限公司 | Composite antibacterial agent and preparation method thereof |
CN101914815A (en) * | 2010-08-17 | 2010-12-15 | 山东大学 | Application of silk in preparation of antibacterial fiber material and antibacterial fiber material |
CN102453317B (en) * | 2010-10-22 | 2013-07-03 | 中国石油化工股份有限公司 | Antibacterial polylactic acid composition and preparation method thereof |
CN102321650B (en) * | 2011-06-27 | 2012-12-26 | 苏州大学 | Method for producing fluorescent antibacterial silks from transgenic silkworms |
CN102936794B (en) * | 2012-11-20 | 2015-01-21 | 东华大学 | Method for preparing composite nanofiber membrane based on natural material silk fibroin and chitosan |
CN103830768A (en) * | 2012-11-21 | 2014-06-04 | 深圳兰度生物材料有限公司 | Degradable wound repair material and preparation method thereof |
CN103184570B (en) * | 2013-04-09 | 2015-08-26 | 南京维赛医药科技有限公司 | A kind of fibroin albumen base antibacterial nano fiber and preparation method thereof |
CN103882718B (en) * | 2014-04-11 | 2015-11-11 | 西南大学 | Nano Silver modifies preparation method of silk and products thereof and application |
CN104264369B (en) * | 2014-10-21 | 2016-08-17 | 天津工业大学 | The method of keratin/PEO biological nano fibrous membrane is prepared in two step crosslinkings |
CN105031714A (en) * | 2015-06-24 | 2015-11-11 | 南通纺织丝绸产业技术研究院 | Adhesive bandage and method for manufacturing same |
CN105401232B (en) * | 2015-11-02 | 2017-09-29 | 浙江纺织服装科技有限公司 | A kind of preparation method of biological dressing composite micro-nano rice tunica fibrosa |
CN105421055A (en) * | 2016-01-18 | 2016-03-23 | 杜名胜 | Moisture-absorbing and perspiring anti-bacterial fabric and preparation technology thereof |
CN105664225A (en) * | 2016-02-24 | 2016-06-15 | 苏州思彬纳米科技有限公司 | Nano-silver, chitosan and fibroin compound biological dressing and preparation method thereof |
CN107217388B (en) * | 2017-06-29 | 2019-09-06 | 天津大学 | Antibacterial poly(ε-caprolactone)/poly(ε-caprolactone)-REDV/gelatin electrospun fiber membrane and preparation method |
CN107714290B (en) * | 2017-09-28 | 2018-09-11 | 江西宜信堂医疗科技有限公司 | A kind of Medical-use cold compress dressing |
CN108379932B (en) * | 2018-02-10 | 2020-09-01 | 北京清科丝宇技术有限公司 | Nanofiber filtering material and air filtering equipment based on same |
CN110158239A (en) * | 2018-03-28 | 2019-08-23 | 山东佳星环保科技有限公司 | A kind of preparation method of antibacterial graphene nano fiber film |
CN108642625A (en) * | 2018-04-25 | 2018-10-12 | 夏津仁和纺织科技有限公司 | Preparation method of the pure cotton from antimicrobial yarn |
CN108704163A (en) * | 2018-05-29 | 2018-10-26 | 苏州先蚕丝绸有限公司 | A kind of preparation method of taste of dispelling, antibacterial, skin care natural silk sanitary napkin |
CN109137511B (en) * | 2018-07-09 | 2020-12-04 | 安徽农业大学 | A kind of chitosan sericin composite finishing agent and finishing method for cotton fabric |
CN108939133B (en) * | 2018-08-07 | 2021-04-30 | 河南汇博医疗股份有限公司 | Antibacterial healing-promoting fibroin wound-protecting material and preparation method thereof |
CN113005532B (en) * | 2019-12-19 | 2022-07-19 | 武汉大学 | A method for continuously preparing silk nanofibers and chitin or chitosan composite fibers |
CN111495211B (en) * | 2020-04-27 | 2021-10-26 | 中南林业科技大学 | Method for preparing high-strength hypha cross-linked water treatment composite membrane based on sugar-containing wastewater |
CN113355804B (en) * | 2021-07-19 | 2023-03-24 | 武汉大学 | Composite nanofiber membrane with biological responsiveness and preparation method and application thereof |
CN113634048B (en) * | 2021-09-10 | 2022-10-14 | 武汉纺织大学 | Natural silk micro-nanofiber composite porous material and its application |
CN113957560A (en) * | 2021-10-26 | 2022-01-21 | 潍坊欣龙生物材料有限公司 | Preparation method of hair protein flame-retardant cellulose fiber |
CN114481441A (en) * | 2021-12-16 | 2022-05-13 | 西安工程大学 | Nano-fiber mask base cloth containing fibroin, functional mask and preparation method of functional mask |
CN114481362A (en) * | 2022-02-14 | 2022-05-13 | 武汉纺织大学 | Preparation method of nano composite fiber spinning solution and nano composite fiber |
-
2006
- 2006-07-13 CN CNB2006100410162A patent/CN100467680C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109468705A (en) * | 2016-12-06 | 2019-03-15 | 宁波芸生纺织品科技有限公司 | A kind of biological fibrous material |
CN109468705B (en) * | 2016-12-06 | 2020-12-29 | 宁波芸生纺织品科技有限公司 | Biological fiber material |
Also Published As
Publication number | Publication date |
---|---|
CN1904159A (en) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100467680C (en) | Antibacterial silk composite nanofiber material and preparation method thereof | |
RU2468129C2 (en) | Biopolymeric fibre, composition of forming solution for its obtaining, method of forming solution preparation, linen of biomedical purpose, biological bandage and method of wound treatment | |
CN103394114B (en) | A kind of preparation method of medical dressing chitosan-based superfine fiber carrier material | |
Naseri et al. | Electrospun chitosan-based nanocomposite mats reinforced with chitin nanocrystals for wound dressing | |
CN103422255B (en) | A kind of preparation method that can be used for medical dressing and contain the composite cellulosic membrane of Nano Silver | |
CN101187111B (en) | Nano-silver gelatin/chitosan composite nanofiber felt for medical dressings and its preparation | |
CN103320967B (en) | Composite electrostatic spinning material containing fullerene and nano-silver for medical dressings and method for manufacturing composite electrostatic spinning material | |
CN101187089A (en) | Antibacterial nanofibers blended with silk fibroin and polyvinyl alcohol and preparation method thereof | |
CN103705969A (en) | Method for preparing chitosan-based silver-loaded composite antimicrobial superfine fiber membrane | |
CN101297976A (en) | Preparation of antibacterial silver/chitosan nano fiber membrane | |
CN102552964B (en) | Nano silver chitosan composite antibacterial composition, adhesive bandage and preparation method of adhesive bandage | |
CN108993167A (en) | A kind of preparation and application of the Electrospun nano-fibers air filting material of antibacterial | |
CN107823692B (en) | Wound dressing composite nanofiber membrane and preparation method thereof | |
CN105664225A (en) | Nano-silver, chitosan and fibroin compound biological dressing and preparation method thereof | |
CN113425884B (en) | A kind of preparation method of three-dimensional nanofiber antibacterial dressing containing nano Cu2O | |
CN107158444A (en) | A kind of antibacterial hyperplasia composite membrane and preparation method thereof | |
Ibrahim et al. | Carboxymethyl chitosan electrospun nanofibers: Preparation and its antibacterial activity | |
CN101914815A (en) | Application of silk in preparation of antibacterial fiber material and antibacterial fiber material | |
CN110025817A (en) | A kind of preparation and application of zein/plants essential oil composite antibacterial fibre dressing | |
CN108159486A (en) | A kind of antibacterial anti hemorrhagic bifunctional material and preparation method thereof | |
CN108498846A (en) | A kind of slow-release chitosan antiseptic dressing and preparation method thereof | |
CN114949325A (en) | A kind of preparation method of composite nanofiber membrane for wound dressing and composite nanofiber membrane | |
CN106178065A (en) | A kind of preparation method carrying Moxifloxacin electrospun membrane antiseptic dressing | |
WO2019018997A1 (en) | Antimicrobial alginate fibre, and preparation method for and use of dressing thereof | |
CN105457076A (en) | Chitosan oligosaccharide-nano-silver antimicrobial dressing and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090311 Termination date: 20110713 |